Blueprint Medicines Soars 26% on $9.5 Billion Buyout. Why This Drug Is Key to the Deal.

Campbell’s Snack Business Struggles as Consumers Get Pickier About Food Spending

Applied Digital and CoreWeave ink 15-year lease worth $7 billion

White Paper: State of the Industry – June 2025

Home Cooking Is Back at Pandemic Levels, Campbell’s Says

Sanofi to Acquire Blueprint Medicines for up to $9.5 Billion to Expand Immunology Portfolio